These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 31456475)
1. Polyethylenimine and sodium cholate-modified ethosomes complex as multidrug carriers for the treatment of melanoma through transdermal delivery. Ma L; Wang X; Wu J; Zhang D; Zhang L; Song X; Hong H; He C; Mo X; Wu S; Kai G; Wang H Nanomedicine (Lond); 2019 Sep; 14(18):2395-2408. PubMed ID: 31456475 [No Abstract] [Full Text] [Related]
2. Bioreducible poly(2-ethyl-2-oxazoline)-PLA-PEI-SS triblock copolymer micelles for co-delivery of DNA minicircles and Doxorubicin. Gaspar VM; Baril P; Costa EC; de Melo-Diogo D; Foucher F; Queiroz JA; Sousa F; Pichon C; Correia IJ J Control Release; 2015 Sep; 213():175-191. PubMed ID: 26184050 [TBL] [Abstract][Full Text] [Related]
3. Bovine serum albumin nanoparticles improve the antitumour activity of curcumin in a murine melanoma model. Camargo LEA; Brustolin Ludwig D; Tominaga TT; Carletto B; Favero GM; Mainardes RM; Khalil NM J Microencapsul; 2018 Aug; 35(5):467-474. PubMed ID: 30246573 [TBL] [Abstract][Full Text] [Related]
4. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide. Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599 [TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies. Zhang YF; Wang JC; Bian DY; Zhang X; Zhang Q Eur J Pharm Biopharm; 2010 Mar; 74(3):467-73. PubMed ID: 20064608 [TBL] [Abstract][Full Text] [Related]
6. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas. Amjad MW; Amin MC; Katas H; Butt AM; Kesharwani P; Iyer AK Mol Pharm; 2015 Dec; 12(12):4247-58. PubMed ID: 26567518 [TBL] [Abstract][Full Text] [Related]
7. Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel. Yu X; Du L; Li Y; Fu G; Jin Y Biomed Pharmacother; 2015 Jul; 73():6-11. PubMed ID: 26211575 [TBL] [Abstract][Full Text] [Related]
8. Nanoparticle assisted solvent selective transdermal combination therapy of curcumin and 5-flurouracil for efficient cancer treatment. Anirudhan TS; Nair AS; Bino SJ Carbohydr Polym; 2017 Oct; 173():131-142. PubMed ID: 28732851 [TBL] [Abstract][Full Text] [Related]
9. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Mangalathillam S; Rejinold NS; Nair A; Lakshmanan VK; Nair SV; Jayakumar R Nanoscale; 2012 Jan; 4(1):239-50. PubMed ID: 22080352 [TBL] [Abstract][Full Text] [Related]
10. [Effects of penetration enhancers on curcumin transdermal drug delivery]. Gao ZS; Wang L; Zhang M Zhong Yao Cai; 2012 Jan; 35(1):141-4. PubMed ID: 22734426 [TBL] [Abstract][Full Text] [Related]
11. Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles. Wang J; Ma W; Tu P Macromol Biosci; 2015 Sep; 15(9):1252-61. PubMed ID: 25981672 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy. Xu C; Wang Y; Guo Z; Chen J; Lin L; Wu J; Tian H; Chen X J Control Release; 2019 Feb; 295():153-163. PubMed ID: 30586598 [TBL] [Abstract][Full Text] [Related]
13. Nano-assemblies of J-aggregates based on a NIR dye as a multifunctional drug carrier for combination cancer therapy. Song X; Zhang R; Liang C; Chen Q; Gong H; Liu Z Biomaterials; 2015 Jul; 57():84-92. PubMed ID: 25913253 [TBL] [Abstract][Full Text] [Related]
14. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets. Baghbani F; Moztarzadeh F Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723 [TBL] [Abstract][Full Text] [Related]
15. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles. Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331 [TBL] [Abstract][Full Text] [Related]
16. Polyvinyl Alcohol/Hydroxyethylcellulose Containing Ethosomes as a Scaffold for Transdermal Drug Delivery Applications. El Fawal G; Hong H; Song X; Wu J; Sun M; Zhang L; He C; Mo X; Wang H Appl Biochem Biotechnol; 2020 Aug; 191(4):1624-1637. PubMed ID: 32198603 [TBL] [Abstract][Full Text] [Related]
17. Albumin nanoparticles with synergistic antitumor efficacy against metastatic lung cancers. Kim B; Seo B; Park S; Lee C; Kim JO; Oh KT; Lee ES; Choi HG; Youn YS Colloids Surf B Biointerfaces; 2017 Oct; 158():157-166. PubMed ID: 28688365 [TBL] [Abstract][Full Text] [Related]
18. Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier. Li JM; Zhang W; Su H; Wang YY; Tan CP; Ji LN; Mao ZW Int J Nanomedicine; 2015; 10():3147-62. PubMed ID: 25960653 [TBL] [Abstract][Full Text] [Related]
19. Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery: Peram MR; Jalalpure S; Kumbar V; Patil S; Joshi S; Bhat K; Diwan P J Liposome Res; 2019 Sep; 29(3):291-311. PubMed ID: 30526186 [TBL] [Abstract][Full Text] [Related]
20. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression. Huang HY; Kuo WT; Chou MJ; Huang YY J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]